CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Viral and paraneoplastic encephalitis in a patient with liver transplant with unilateral temporoparietal lobe abnormalities: a diagnostic challenge.

We report a patient who recently had a liver transplant presented with increasing confusion and intermittent hallucinations. MRI of the brain revealed diffuse left temporal and parietal lobe swelling with cortical diffusion restriction suggestive of possible infectious aetiology, although stroke was also possible given the presence of left posterior cerebral arteries with fetal origin in the anterior circulation. An EEG demonstrated subclinical seizures, for which he was placed on an antiepileptic medication. Routine laboratory testing, lumbar puncture, serum and cerebrospinal fluid testing for viral and paraneoplastic encephalitis, and brain biopsy were performed on our patient. Our clinical diagnosis was viral encephalitis, and positive N-type voltage-gated calcium channel antibody titres were suggestive of paraneoplastic limbic encephalitis. Treatment with antiviral and antiepileptic medications for subclinical seizures resulted in the improvement of his mental status, language output and motor functioning.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app